Yellow Laser is an advanced laser surgery performed for the treatment of a multitude of macular diseases like diabetic Macular Edema, CSCR (Central Serous Retinopathy) and ARMD (Age-Related Macular Degeneration). The Yellow Laser heralds a new beginning in the area of Diabetic Retinopathy, as it has proved to be extremely effective and safer than conventional Green Laser.

The Yellow Laser is the ideal wavelength for Micropulse sub-thresholds laser treatment for diabetic macula edema, CSCR etc. Here, the exposures are as low as 10 milliseconds (for conventional lasers, 100 milliseconds are the lowest duration). This enables laser treatment with no visible endpoint or damaged tissue.

Yellow Laser is especially useful among patients who fail to respond to Intra-ocular injections and in whom the injections are contraindicated. Yellow Laser scores better safety margins for macular treatment as compared to the conventional Green Laser. This is due to the fact that yellow wavelength is only negligibly absorbed by the macular xanthophylls, a pigment present in macula, whereas green laser has the same absorption spectrum as the macular xanthophylls. Therefore, it is safe to say that Yellow Laser is the safest wavelength for the treatment of any pathologies close to Macula.

Yellow-Laser
Picture 1.

Often, a discussion arises about the comparison of Yellow Laser with that of Conventional Green Laser, though both are equally used in curing macular diseases.
Contrary to Conventional Green Laser, the Yellow Laser is preferred in following circumstances, producing fruitful results:

A. Patients with media opacities – Cataract and Vitreous Haemorrhage

In these conditions, Yellow Laser (longer wavelength of 577 nm) wave exhibits low light scattering with more accurate intraocular transit and superior transmission through media opacities. In this way, the desired tissue reaction is achieved.

Unlike Yellow Laser, the Conventional Green Laser (wavelength -532 nm) does not penetrate the eye entirely due to significant scattering of light and hence fails to give good tissue reaction.

Diabetic-Retinopathy
Picture 2. Slit lamp photograph of a patient with a cataract

B. Patients with poor retinal pigmentation

In this case, the Yellow Laser provides a more consistent effect on patients (elderly) with light or irregular fundus pigmentation. The predominant chromophore for the Yellow Laser is haemoglobin, uniformly distributed throughout the retina from beneath the choriocapillaris and choroid unlike melanin (predominant chromophore for Green Laser), which has varied levels of distribution in the same eye. This property of Yellow Laser is highly beneficial in treating patients with poor pigmentation.

Following are photo shots of a patient before and after Yellow Laser Treatment treated at Neoretina Eyecare Institute:

Diabetic-RetinopathyMacula-EdemaConventional-Green-Laser
Picture 3. Fundus photos showing hazily old BRVO (Branch Retinal Vein Occlusion) with new vessels in a patient with significant cataract. These eyes with such significant cataract cannot be lasered with the conventional Green Laser.

Conventional-Green-Laser
Picture 4. Fundus photos of the same patient Post pattern sector PRP laser with a Yellow Laser at Neoretina

In 2014, in the Institute’s relentless efforts to provide advanced state-of-the-art eye care facility, Yellow Laser treatment was launched at Neoretina, being the first to do so in the then Andhra Pradesh. The hospital has so far registered innumerable successful laser surgeries with latest equipment, thus propelling them into a whole new league in retina care.

Dr. Raja Rami Reddy P

Dr. Raja Rami Reddy P

MD FRCS (Glasg), Chief Retina Surgeon, Founder & Medical Director at Neoretina
Dr. Reddy is a renowned specialist in retinal surgery with more than 20 years’ experience in the field. He is the Founder, Director and Chief Retinal Surgeon at NEORETINA Eyecare Institute, Hyderabad, which is a foremost referral centre for diseases of the Retina. His areas of expertise include Surgical Retina especially complicated vitreo-retinal surgeries for retinal detachment, vitreous hemorrhage, advanced diabetic retinopathy, macular holes and epiretinal membranes. He studied MBBS and MD at the prestigious All India Institute of Medical Sciences, New Delhi and was a Specialist Registrar at the Vitreo-Retina Department of the reputed Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi. He is a member of the American Society of Retinal Surgeons and is an active member of the state and national academic societies.
Dr. Raja Rami Reddy P